Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 350000
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Good margins and returns
Data is available to registered users only
Data is available to registered users only
About
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Data is available to registered users only
Target Price
The average target price of 128940.KS is 364986 and suggests 4% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommend
Data is available to registered users only
